This study aims to compare the efficacy of anti-Xa based versus weight-based enoxaparin dosing and to evaluate anti-Xa levels as a predictive tool for clinical outcomes in burn patients
Adults (≥21 years) admitted to the burn unit with thermal burns ≥20% TBSA and < 60%.
Admission to BICU within 48 hours of burn injury.
Indication for VTE prophylaxis (e.g., immobilized, surgical intervention).
Ability to provide informed consent
Pre-existing coagulopathy or anticoagulant therapy prior to injury.
Patients with severe comorbidities (e.g., end-stage renal failure, advanced malignancy, hepatic disease).
Need for therapeutic anticoagulant therapy.
patients with extremes of weight, (45kg >=weight >= 150kg).